Seven Bridge Financial Group, LLC Gilead Sciences, Inc. Transaction History

Seven Bridge Financial Group, LLC

$478 Million
Q1 2025

A detailed history of Seven Bridge Financial Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 8,696 shares of GILD stock, worth $923,428. This represents 0.2% of its overall portfolio holdings.

Number of Shares

8,696

Previous 10,080 13.73%

Holding current value

$923,428

Previous $931,000 4.62%

% of portfolio

0.2%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$89.14 - $117.41 $123,369 - $162,495	-1,384 Reduced 13.73%	8,696 $974,000
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $14,524 - $16,762	-230 Reduced 2.23%	10,080 $691,000
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $205,792 - $250,958	-2,875 Reduced 21.81%	10,310 $755,000
Q4 2023 Jan 22, 2024	SELL	$73.27 - $83.09 $57,297 - $64,976	-782 Reduced 5.6%	13,185 $1.07 Million
Q3 2023 Oct 25, 2023	BUY	$73.94 - $80.67 $192,244 - $209,742	2,600 Added 22.87%	13,967 $1.05 Million
Q2 2023 Jul 26, 2023	BUY	$76.01 - $86.7 $140,390 - $160,134	1,847 Added 19.4%	11,367 $876,000
Q1 2023 Apr 20, 2023	BUY	$77.31 - $88.08 $40,974 - $46,682	530 Added 5.9%	9,520 $789,000
Q4 2022 Jan 26, 2023	BUY	$62.32 - $89.47 $15,268 - $21,920	245 Added 2.8%	8,990 $0
Q3 2022 Oct 17, 2022	BUY	$59.54 - $68.01 $520,677 - $594,747	8,745 New	8,745 $539,000
Q3 2020 Oct 22, 2020	SELL	$62.1 - $78.08 $165,620 - $208,239	-2,667 Closed	0 $0
Q2 2020 Jul 24, 2020	BUY	$72.34 - $84.0 $192,930 - $224,028	2,667 New	2,667 $205,000
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $196,691 - $216,353	-3,192 Closed	0 $0
Q3 2019 Oct 09, 2019	SELL	$62.51 - $69.0 $17,190 - $18,975	-275 Reduced 7.93%	3,192 $202,000
Q2 2019 Jul 15, 2019	SELL	$61.87 - $69.38 $10,456 - $11,725	-169 Reduced 4.65%	3,467 $234,000
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $19,696 - $22,065	315 Added 9.49%	3,636 $236,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $62,356 - $81,370	-1,030 Reduced 23.67%	3,321 $208,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $6,130 - $6,787	-86 Reduced 1.94%	4,351 $336,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $17,517 - $20,433	-270 Reduced 5.74%	4,437 $314,000
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $11,290 - $13,764	-155 Reduced 3.19%	4,707 $355,000
Q4 2017 Feb 20, 2018	BUY	$71.15 - $83.52 $19,210 - $22,550	270 Added 5.88%	4,862 $348,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $104,198 - $123,504	1,445 Added 45.92%	4,592 $372,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,147	3,147 $223,000

Others Institutions Holding GILD

# of Institutions

2,288

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $133B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.

Account

Seven Bridge Financial Group, LLC Gilead Sciences, Inc. Transaction History